Related Experiment Video
Updated: May 23, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
[Metastatic melanoma: some hope from ipilimumab and vemurafenib]
C Piérard-Franchimont1, G E Piérard
1Service de Dermatopathologie, CHU de Liège, Belgique. claudine.franchimont@ulg.ac.be
Abstract:
Treating a patient with cutaneous malignant melanoma relies on the recognition of a clever stratification of the distinct stages of the disease. The histoprognostic criteria were recently revisited. In addition, translational research fueled the development of new treatments with at last increased efficacy in the metastatic stage. Such therapeutic advance improves the median overall survival for a few months. Some combined treatments could possibly boost the beneficial effects.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
Treatment Resistant Cancers
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...

